In some countries such as France, Italy, Spain and the Balkan region, Menarini Group will lead the commercialisation effort, as part of an exclusive licensing agreement signed with Glenmark
The IPO comprises a fresh issue of up to Rs. 11,600 million and an offer for sale of up to 7,305,245 equity shares of Rs. 2 each of Glenmark Life Sciences by Glenmark Pharmaceuticals
Candid Powder brand is a market-leader in its category, with a market share of 64% in the medicated powder category.
India business grew 11.8% YoY vs mid-single digit industry growth.
The jump in profit is due to the better performance of the API business.
According to IQVIA sales data for the 12 month period ending December 2020, the Cleocin T Gel, 1% market achieved annual sales of approximately $73.8 million.
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
The company has posted net profit of Rs. 485.62 crores for the Financial Year ended March 31, 2025
EBITDA margins expand to 31.3%
Subscribe To Our Newsletter & Stay Updated
